| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
|
J Clin Oncol
|
2013
|
5.21
|
|
2
|
Therapeutic antibody targeting of individual Notch receptors.
|
Nature
|
2010
|
4.56
|
|
3
|
Somatic mutations lead to an oncogenic deletion of met in lung cancer.
|
Cancer Res
|
2006
|
3.12
|
|
4
|
Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.
|
Cancer Res
|
2006
|
2.84
|
|
5
|
Bad-deficient mice develop diffuse large B cell lymphoma.
|
Proc Natl Acad Sci U S A
|
2003
|
2.54
|
|
6
|
The mitochondrial inner membrane protein mitofilin controls cristae morphology.
|
Mol Biol Cell
|
2005
|
2.53
|
|
7
|
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.
|
Cancer Res
|
2008
|
2.33
|
|
8
|
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.
|
Cancer Discov
|
2011
|
2.22
|
|
9
|
Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation.
|
Dev Biol
|
2005
|
1.54
|
|
10
|
Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.
|
Proc Natl Acad Sci U S A
|
2007
|
1.54
|
|
11
|
Uniform nomenclature for the mitochondrial contact site and cristae organizing system.
|
J Cell Biol
|
2014
|
1.34
|
|
12
|
Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis.
|
Differentiation
|
2006
|
1.29
|
|
13
|
Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
|
Cancer Res
|
2008
|
1.28
|
|
14
|
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer.
|
Cancer Res
|
2012
|
1.23
|
|
15
|
Navitoclax enhances the efficacy of taxanes in non-small cell lung cancer models.
|
Clin Cancer Res
|
2011
|
1.23
|
|
16
|
Navitoclax (ABT-263) reduces Bcl-x(L)-mediated chemoresistance in ovarian cancer models.
|
Mol Cancer Ther
|
2012
|
1.20
|
|
17
|
The double-histone-acetyltransferase complex ATAC is essential for mammalian development.
|
Mol Cell Biol
|
2008
|
1.09
|
|
18
|
Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors.
|
Neoplasia
|
2011
|
0.98
|
|
19
|
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake.
|
Mol Cancer Ther
|
2008
|
0.98
|
|
20
|
Prostate-specific Klf6 inactivation impairs anterior prostate branching morphogenesis through increased activation of the Shh pathway.
|
J Biol Chem
|
2009
|
0.96
|
|
21
|
Polyubiquitination of insulin-like growth factor I receptor (IGF-IR) activation loop promotes antibody-induced receptor internalization and down-regulation.
|
J Biol Chem
|
2011
|
0.93
|
|
22
|
Characterization of ML-IAP protein stability and physiological role in vivo.
|
Biochem J
|
2012
|
0.91
|
|
23
|
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
|
Adv Anat Pathol
|
2017
|
0.75
|
|
24
|
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
|
Adv Anat Pathol
|
2017
|
0.75
|